Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials-Reference-Cited by-同舟云学术

Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials

Published:2016-12-09 Issue:4 Volume:105 Page:485-496
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Nakane Takahiko,Nakamae Hirohisa,Yamaguchi Takuhiro,Kurosawa Saiko,Okamura Atsuo,Hidaka Michihiro,Fuji Shigeo,Kohno Akio,Saito Takeshi,Aoyama Yasutaka,Hatanaka Kazuo,Katayama Yoshio,Yakushijin Kimikazu,Matsui Toshimitsu,Yamamori Motohiro,Takami Akiyoshi,Hino Masayuki,Fukuda Takahiro

Funder

26-A-26

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-2154-4.pdf

Reference36 articles.

1. Bornhäuser M, Schuler U, Pörksen G, Naumann R, Geissler G, Thiede C, et al. Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Transplantation. 1999;67:499–504.

2. Bolwell B, Sobecks R, Pohlman B, Andresen S, Rybicki L, Kuczkowski E, et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;34:621–5.

3. Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT, et al. A A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:495–505.